Crystal structure of oxibendazole, C12H15N3O3

被引：0
|
作者：
Kaduk, James A. A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. N. [3 ]
机构：
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
来源：
POWDER DIFFRACTION | 2023年 / 38卷 / 01期
关键词：
oxibendazole; Loditac; powder diffraction; Rietveld refinement; density functional theory; POWDER; VALIDATION; PATTERNS; DENSITY;
D O I：
10.1017/S0885715622000495
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
The crystal structure of oxibendazole has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Oxibendazole crystallizes in space group C2/c (#15) with a = 23.18673(22), b = 5.35136(5), c = 19.88932(13) angstrom, beta = 97.0876(9)degrees, V = 2449.018(17) angstrom(3), and Z = 8. The structure consists of hydrogen-bonded layers of planar molecules parallel to the bc-plane. Strong N-HMIDLINE HORIZONTAL ELLIPSISN hydrogen bonds link the molecules into dimers, with a graph set R2,2(8). N-HMIDLINE HORIZONTAL ELLIPSISO hydrogen bonds further link these dimers into layers parallel to the bc-plane. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码：15 / 20
页数：6
相关论文
共 50 条
  • [21] Crystal structure of bumetanide, C17H20N2O5S
    Diulus, Samantha C.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (02) : 189 - 195
  • [22] Crystal structure of cephalexin monohydrate, C16H17N3O4S(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (04) : 293 - 300
  • [23] Crystal structure of baricitinib, C16H17N7O2S
    Lee, Yewon
    Wang, Yulong
    Khalifah, Peter G.
    Stephens, Peter W.
    Kaduk, James A.
    Gates-Rector, Stacy
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (03) : 150 - 156
  • [24] Crystal structure of etrasimod, C26H26F3NO3
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2025,
  • [25] Crystal structure of metolazone, C16H16ClN3O3S
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (04) : 361 - 367
  • [26] Crystal structure of alfuzosin hydrochloride, C19H28N5O4Cl
    Kaduk, James A.
    POWDER DIFFRACTION, 2022, 37 (03) : 171 - 182
  • [27] Crystal structure of fulvestrant hydrate (ethyl acetate), C32H47F5O3S(H2O)0.16(C4H8O2)0.025
    Kaduk, James A.
    Boaz, Nicholas C.
    Gates-Rector, Stacy D.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (03) : 157 - 165
  • [28] Crystal structure of nicarbazin, (C13H10N4O5)(C6H8N2O)
    Kaduk, James A.
    Dosen, A.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (02) : 105 - 110
  • [29] Crystal structure of levocetirizine dihydrochloride Form I, C21H27ClN2O3Cl2
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (03) : 181 - 189
  • [30] Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 43 - 52
12345